What You Should Know:
- TRIPP, a Los Angeles-based digital psychedelic platform, announced it has raised $11M in funding led by Vine Ventures, and Mayfield with equal participation from Integrated. TRIPP’s Series A also includes particpation from AlphaBridge Ventures, Beni VC, Berkeley Club, CJ Group, CTR Capital, Evolution, Robert Goldberg, Tony Greenberg, Grit VC, Incisive Ventures, Inflect Health, Iter Investments, Joanna Popper, Jim Dew, Joe Polish, JLS Fund, Lionheart Ventures,
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Hims & Hers Acquires Teledermatology Platform Apostrophe
What You Should Know:
-Hims & Hers Health, Inc., the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced its will acquire teledermatology specialist, Apostrophe. Financial details of the transaction will not be disclosed at this time.
Apostrophe has created a clinical platform that powers bespoke treatment plans that include some of the most sophisticated, personalized combinations of topical
Read More
Providence-backed Tegria Acquires Digital Health AI Platform KenSci
What You Should Know:
- Providence-backed Tegria today announced the acquisition of KenSci, a leader in artificial intelligence platforms and apps for healthcare, with roots in Microsoft's Azure4Research program and the University of Washington. Financial details of the acquisition were not disclosed.
- Founded in 2015, KenSci's digital health AI platform helps organizations bring the power their data and improve health outcomes with advanced analytics. KenSci's customers,
Read More
Medable Launches Decentralized Clinical Trials Enablement Program
What You Should Know:
- Medable Inc., a software platform for patient-centered drug development, today announced an industry-first digital certification program that provides life sciences companies with specialized tools, knowledge sharing and skills development to rapidly scale their decentralized and hybrid trial strategies.
- Hybrid/decentralized clinical trials have unleashed an entirely new patient experience, but this new approach to clinical research will only work if
Read More
Cardiac Success Secures $5.2M for Transcatheter Ventricular Repair Device for Heart Failure Patients
What You Should Know:
- Cardiac Success Ltd., an Israel-based medical device company developing a transcatheter ventricular repair device for heart failure patients, announced it has raised $5.2M in Series A funding round led by 415 CAPITAL. The round was joined by an unnamed global strategic leader in structural heart interventions and a group of Israeli angel investors.
- Today, there are millions of patients who, despite guidance-directed medical therapy, continue to suffer
Read More
Naborforce Raises $2M to Expand Social Engagement, On-Demand Support for Older Adults
What You Should Know:
- Naborforce, a Richmond, VA-based company connecting aging adults to a network of trusted care providers for companionship and on-demand support, announced it has raised $2M in seed funding led by Claritas Capital.
- Inspired by JOY to promote engaged, productive and connected aging and living, Naborforce's tech enabled platform connects aging adults to a network of “Nabors” for social engagement and on-demand support with errands, transportation and help around the
Read More
U of Chicago Med & COTA to Address Racial Disparities in Cancer Using RWD
What You Should Know:
- COTA, Inc., an oncology real-world data and analytics company and the University of Chicago Medicine announced a research collaboration agreement to investigate racial disparities of care in multiple myeloma to better understand differences in the diagnosis, treatment patterns, and outcomes of patients with this type of cancer.
- Multiple myeloma is the second-most-common hematologic malignancy, with an estimated 34,920 new cases and 12,410 deaths expected to occur
Read More
Aetna Launches Specialty Provider Network for Suicide Prevention with Psych Hub
What You Should Know:
- Today, Aetna, a CVS Health company announced the launch of a specialty provider network with a sole focus on suicide prevention in collaboration with Psych Hub, a comprehensive platform for mental health education. The joint effort will further arm Aetna practitioners with no-cost, evidence-based instruction, tools, and resources to identify and treat those at risk of suicide.
- As part of the collaboration, 83,000 behavioral health and employee assistance program
Read More
Lightship Partners with Castor to Scale Virtual Clinical Trials Worldwide
- Lightship and Castor, providers of decentralized clinical trial solutions, today announced a strategic partnership to run direct-to-patient (hybrid) clinical trials at scale. The partnership combines operational excellence in clinical studies and technology that delivers for the most complex clinical trials.
- Lightship’s end-to-end delivery model combined with an in-house care team provide the best possible patient experience in clinical trials.
- By partnering with Castor’s
Read More
Pear Therapeutics Goes Public Via $1.6B SPAC Deal – Digital Health IPO
What You Should Know:
- Pear Therapeutics, the leader in developing and commercializing prescription digital therapeutics to treat serious disease, and Thimble Point Acquisition Corp (Nasdaq: THMA), a special purpose acquisition company (SPAC) whose management team is associated with the Pritzker Vlock Family Office, today announced that they have entered into a definitive business combination agreement.
- Pursuant to the Business Combination Agreement, upon closing of the
Read More
